MENU

ADHD

Learn More

44 % Reduction in Symptoms of ADHD*

Children ages 7–14 demonstrated significant reductions in ADHD symptoms after 4 weeks of eTNS without the side effects of medication.

Learn More

Depression

Learn More

52 % Symptom Reduction in Major Depression*

The Monarch eTNS System offers a safe, non-invasive approach for the treatment of major depression, with virtually no side effects.

Learn More

Epilepsy

Learn More

50 % Or More Reduction in Seizures in 40% of Subjects*

Separate clinical trials showed the Monarch eTNS System to be a safe and effective treatment for epilepsy.

Learn More

Designed in California by a Team of Doctors from UCLA

Find Out How to Get a
Monarch eTNS System
Information
for Physicians

Explore How the Monarch eTNS Works

Monarch for ADHD

ADHD is one of the most commonly diagnosed conditions in school age children and is increasingly recognized as an issue that persists into adulthood. Unfortunately, current ADHD treatment is focused on prescription of stimulant medications that can have worrisome side effects.

eTNS is a new treatment for patients with ADHD that is easy to use and doesn’t have the side effects of medication.

In a recently-completed study of school age children with ADHD, nightly use of eTNS resulted in significant reductions of ADHD symptoms in as little as 4 weeks. Results were similar to those achieved with stimulant medications and patients reported only mild side effects.

Learn More Learn More

Monarch for Depression

Depression is a common and disabling medical condition. Many individuals continue to suffer from severe depression despite trying multiple antidepressant medications, often in combination. Few effective options are available to people whose depression is resistant to drug therapies.

Cranial nerve stimulation has been used to treat depression for more than a decade, but the Monarch eTNS System is the first safe and effective system that does not require surgery.

The eTNS system was developed and tested by doctors at the University of California, Los Angeles (UCLA). The eTNS system offers an especially attractive option because it does not require surgery and has been shown to be successful at treating patients with medication resistant depression.

Learn More Learn More

Monarch for Epilepsy

Treatment of epilepsy with eTNS is easy and convenient.
Patients use the system in the comfort of their own home. Until recently, vagus nerve stimulation (VNS), which requires a surgically-implanted device, was the only cranial nerve stimulation available to epilepsy patients.

The Monarch eTNS system offers a new path for epilepsy patients by providing safe and effective cranial nerve stimulation with a device that does not require surgery.

Physicians at the University of California, Los Angeles (UCLA) invented the eTNS System and separate clinical trials showed it to be safe and effective for treating epilepsy. Patients receiving eTNS also experienced significant improvements in mood and depressive symptoms, making eTNS unique among epilepsy treatments.

Learn More Learn More